IN8bio launches at-the-market equity program with JonesTrading, 3% sales commission

In8bio

In8bio

INAB

0.00
  • IN8bio entered an at-the-market equity distribution agreement with JonesTrading for sales of common stock from time to time.
  • Sales, if any, will be made under its existing Form S-3 shelf registration statement.
  • JonesTrading will receive a 3% commission on gross proceeds from shares sold under the program.
  • IN8bio has no obligation to sell shares under the agreement.
  • Either party can terminate with 10 days’ written notice; the agent can also terminate immediately under specified events.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IN8BIO Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-249684), on June 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.